Sharei Armon 4
4 · SQZ Biotechnologies Co · Filed Jan 13, 2022
Insider Transaction Report
Form 4
Sharei Armon
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2022-01-12$1.81/sh+13,000$23,530→ 285,448 total - Exercise/Conversion
Stock Option
2022-01-12$1.81/sh−13,000$23,530→ 171,937 totalExercise: $1.81Exp: 2026-10-10→ Common Stock (13,000 underlying)
Footnotes (2)
- [F1]Options were exercised and held for tax planning purposes.
- [F2]The option was originally granted for 286,514 shares. The option vested and became exercisable as to the original share amount as to 25% of the underlying securities on October 11, 2017 and in 36 equal monthly installments thereafter.